The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 7.21%.However, over the last six months, we can see a stronger performance of -42.83%. Over the last 30 days, the price of VCYT has leaped by -4.74%. And in the last five days, it has surged by 7.17%.
At present, Veracyte Inc (VCYT) has a stock price of $25.2. In the previous session, the stock saw a rise, peaking at $45.0 after an opening price of $25.1. The day’s lowest price was $29.0, and it closed at $23.59.
Veracyte Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $47.32 on 01/30/25 and the lowest value was $19.73 on 08/05/24.
52-week price history of VCYT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Veracyte Inc’s current trading price is -46.75% away from its 52-week high, while its distance from the 52-week low is 27.70%. The stock’s price range during this period has varied between$19.73 and $47.32. The Veracyte Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.93 million for the day, a figure considerably higher than their average daily volume of 1.01 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Veracyte Inc (VCYT) has experienced a quarterly decline of -21.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.97B and boasts a workforce of 824 employees.
Veracyte Inc: Analysts’ Ratings Unveiled
As of right now, 7 analysts are rating Veracyte Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 28.90, with a change in price of -8.30. Similarly, Veracyte Inc recorded 1,015,915 in trading volume during the last 100 days, posting a change of -24.73%.
VCYT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VCYT stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.04.
VCYT Stock Stochastic Average
Veracyte Inc’s raw stochastic average for the past 50 days is presently 37.06%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 49.63%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 32.65% and 24.20%, respectively.
